News | June 27, 2011

CT Angiography Improves Detection of Heart Disease in African-Americans

June 27, 2011 — Researchers may have discovered one reason that African-Americans are at increased risk for heart attacks and other cardiovascular events.

According to a new study published online in the journal Radiology, African-Americans have increased levels of non-calcified plaque, which consists of buildups of soft deposits deep in the walls of the arteries that are not detected by some cardiac tests. Non-calcified plaque is more vulnerable to rupturing and causing a blood clot, which could lead to a heart attack or other cardiovascular event.

According to the U.S. Department of Health and Human Services, African-American adults are more likely to be diagnosed with coronary heart disease and are at greater risk of death from heart disease than white adults. In 2007, African-American men were 30 percent more likely than non-Hispanic white men to die from heart disease.

“For a long time, physicians have searched for explanations as to why African-Americans have higher rates of heart disease and higher cardiac death rates, but less coronary artery calcium than Caucasians,” said U. Joseph Schoepf, M.D., professor of radiology and medicine and director of cardiovascular imaging at Medical University of South Carolina in Charleston. “We show that one possible explanation for the discrepancy may be found in the higher rate of less stable, non-calcified plaque in the heart vessels of African-Americans.”

Calcium scoring with computed tomography (CT) is a common screening tool for patients at risk for cardiovascular disease because increased levels of calcified plaque in the coronary arteries generally links to a greater risk of heart attack or other cardiovascular event. However, calcium scoring does not detect non-calcified plaque.

For the study, researchers compared 301 patients who underwent both calcium scoring with CT and contrast-enhanced coronary CT angiography (cCTA). cCTA provides a more comprehensive picture of the arteries, including the presence of non-calcified and mixed plaques.

The study group comprised 50 percent each of African-American and white patients, 33 percent of whom were male (mean age 55).

Calcium scoring revealed that calcified plaque was much more prevalent in the coronary arteries of white patients than in African-Americans (45 percent versus 26 percent). The cCTA revealed that, compared with the white patients, many more African-American patients had non-calcified plaque (64 percent versus 41 percent), and in greater amounts. The median volume of non-calcified plaque among the African-American patients was 2.2 milliliters (mL), compared with 1.4 mL among white patients.

Based on these results, the researchers suggest that the value of calcium scoring as a screening tool for African-Americans should be reexamined.

“The results of coronary artery calcium scoring studies are to be treated with caution in African-Americans, because they may not reflect the true extent of cardiovascular disease,” Dr. Schoepf said.

While cCTA does expose patients to ionizing radiation, according to Dr. Schoepf, the effective dose of this procedure has been considerably reduced over the past few years, making it a viable screening option if other prerequisites of a successful screening test are also met.

“For African-American patients, coronary CT angiography may be a more appropriate screening tool for cardiovascular risk,” he said.

For more information: http://radiology.rsna.org/

Related Content

Lexington Begins HeartSentry Clinical Trial
News | Clinical Study | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init